<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02502851</url>
  </required_header>
  <id_info>
    <org_study_id>SK 108 -- 120/14</org_study_id>
    <nct_id>NCT02502851</nct_id>
  </id_info>
  <brief_title>The Comparison of Strategies to PREPARE Severely CALCified Coronary Lesions Trial (PREPARE-CALC)</brief_title>
  <acronym>PREPARE-CALC</acronym>
  <official_title>The Comparison of Strategies to PREPARE Severely CALCified Coronary Lesions Trial (PREPARE-CALC): A Prospective Randomized Controlled Trial of Rotational Atherectomy Versus Cutting/Scoring Balloon in Severely Calcified Coronary Lesions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Herz-Kreislauf-Zentrum Segeberger Kliniken GmbH</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Herz-Kreislauf-Zentrum Segeberger Kliniken GmbH</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study is to evaluate the success of lesion preparation with
      either rotational atherectomy or cutting/scoring balloons as well as the long term effects of
      a hybrid sirolimus-eluting stent in an angiographically well-defined group of patients with
      complex calcified coronary lesions.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>September 2014</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">August 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Strategy Success</measure>
    <time_frame>Intraprocedural</time_frame>
    <description>The primary endpoint will be 'Strategy Success' defined as successful stent delivery and expansion with attainment of &lt; 20% in-stent residual stenosis of the target lesion in the presence of TIMI 3 flow without crossover or stent failure</description>
  </primary_outcome>
  <primary_outcome>
    <measure>In-Stent late lumen loss at 9 months</measure>
    <time_frame>9 months</time_frame>
    <description>Co-primary Endpoint: The in-stent late lumen loss at 9 months, defined as the difference between the postprocedure in-stent minimal lumen diameter (MLD) and the in-stent MLD at 9-month followup angiography.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Target vessel failure (TVF)</measure>
    <time_frame>9 months, 1 year, 2 years</time_frame>
    <description>Target vessel failure (TVF) defined as a composite of cardiac death, target vessel related myocardial infarction (MI; Q- or non-Q-wave) and clinically driven target vessel revascularization (TVR) at 9 months, 1 and 2 years</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>In-segment late lumen loss at 9 months</measure>
    <time_frame>9 months</time_frame>
    <description>In-segment late lumen loss (stent length + 5 mm on either side) at 9 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>In-segment binary restenosis at 9 months</measure>
    <time_frame>9 months</time_frame>
    <description>In-segment binary restenosis (diameter stenosis ≥ 50%) at 9 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stent thrombosis at 9 months, 1 and 2 years</measure>
    <time_frame>9 months, 1 and 2 years</time_frame>
    <description>Stent thrombosis at 9 months, 1 and 2 years</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Peri-procedural MI</measure>
    <time_frame>within 72 hrs</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Procedural duration</measure>
    <time_frame>Intraproedural</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Amount of contrast dye</measure>
    <time_frame>Intraprocedural</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">200</enrollment>
  <condition>Coronary Atherosclerosis Due to Severely Calcified Coronary Lesion</condition>
  <arm_group>
    <arm_group_label>Rotational Atherectomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Calcified lesion preparation using rotational atherectomy followed by implantation of the ORSIRO sirolimus-eluting stent</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cutting/Scoring Balloon</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Calcified lesion preparation using cutting/scoring balloon followed by implantation of the ORSIRO sirolimus-eluting stent</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Rotational Atherectomy</intervention_name>
    <description>Calcified lesion preparation using rotational atherectomy before implantation of the Orsiro drug eluting stent</description>
    <arm_group_label>Rotational Atherectomy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cutting/Scoring Balloon</intervention_name>
    <description>Calcified lesion preparation using cutting/scoring balloons before implantation of the Orsiro drug eluting stent</description>
    <arm_group_label>Cutting/Scoring Balloon</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Clinical inclusion criteria

               -  Age above 18 years and consentable

               -  Angiographically proven coronary artery disease

               -  Anginal symptoms and/or reproducible ischemia in the target area by ECG,
                  functional stress testing or fractional flow reserve

               -  Written informed consent

          2. Angiographic inclusion criteria

               -  De-novo lesion in a native coronary artery

               -  Target reference vessel diameter between 2.25 and 4.0 mm by visual estimation

               -  Luminal diameter reduction of 50-100% by visual estimation

               -  Severe calcification of the target lesion

        Exclusion Criteria:

          1. Clinical exclusion criteria

               -  Myocardial infarction (within 1 week)

               -  Decompensated heart failure

               -  Limited long term prognosis due to other conditions

          2. Angiographic exclusion criteria

               -  Target lesion is in a coronary artery bypass graft

               -  Target lesion is an in-stent restenosis

               -  Target vessel thrombus
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mohamed Abdel-Wahab, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Segeberger Kliniken GmbH</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Segeberger Kliniken GmbH</name>
      <address>
        <city>Bad Segeberg</city>
        <state>Schleswig-Holstein</state>
        <zip>23795</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Kawaguchi R, Tsurugaya H, Hoshizaki H, Toyama T, Oshima S, Taniguchi K. Impact of lesion calcification on clinical and angiographic outcome after sirolimus-eluting stent implantation in real-world patients. Cardiovasc Revasc Med. 2008 Jan-Mar;9(1):2-8. doi: 10.1016/j.carrev.2007.07.004.</citation>
    <PMID>18206630</PMID>
  </reference>
  <reference>
    <citation>Kuriyama N, Kobayashi Y, Yamaguchi M, Shibata Y. Usefulness of rotational atherectomy in preventing polymer damage of everolimus-eluting stent in calcified coronary artery. JACC Cardiovasc Interv. 2011 May;4(5):588-9. doi: 10.1016/j.jcin.2010.11.017.</citation>
    <PMID>21596335</PMID>
  </reference>
  <reference>
    <citation>Madhavan MV, Tarigopula M, Mintz GS, Maehara A, Stone GW, Généreux P. Coronary artery calcification: pathogenesis and prognostic implications. J Am Coll Cardiol. 2014 May 6;63(17):1703-14. doi: 10.1016/j.jacc.2014.01.017. Epub 2014 Feb 12. Review.</citation>
    <PMID>24530667</PMID>
  </reference>
  <reference>
    <citation>Abdel-Wahab M, Richardt G, Joachim Büttner H, Toelg R, Geist V, Meinertz T, Schofer J, King L, Neumann FJ, Khattab AA. High-speed rotational atherectomy before paclitaxel-eluting stent implantation in complex calcified coronary lesions: the randomized ROTAXUS (Rotational Atherectomy Prior to Taxus Stent Treatment for Complex Native Coronary Artery Disease) trial. JACC Cardiovasc Interv. 2013 Jan;6(1):10-9. doi: 10.1016/j.jcin.2012.07.017. Epub 2012 Dec 19.</citation>
    <PMID>23266232</PMID>
  </reference>
  <reference>
    <citation>Mooney M, Teirstein P, Moses J, Turco M, Reisman M, Waksman R, Saucedo J, Mauri L, Lee D, Gershony G, Mehran R, Carlier S, Lansky A, Leon M. Final Results from the U.S. Multi-Center Trial of the AngioSculpt Scoring Balloon Catheter for the Treatment of Complex Coronary Artery Lesions. Am J Cardiol 2006;98:121.</citation>
  </reference>
  <reference>
    <citation>Fonseca A, Costa Jde R Jr, Abizaid A, Feres F, Abizaid AS, Costa R, Staico R, Mattos LA, Sousa AG, Grube E, Sousa JE. Intravascular ultrasound assessment of the novel AngioSculpt scoring balloon catheter for the treatment of complex coronary lesions. J Invasive Cardiol. 2008 Jan;20(1):21-7.</citation>
    <PMID>18174614</PMID>
  </reference>
  <reference>
    <citation>Vaquerizo B, Serra A, Miranda F, Triano JL, Sierra G, Delgado G, Puentes A, Mojal S, Brugera J. Aggressive plaque modification with rotational atherectomy and/or cutting balloon before drug-eluting stent implantation for the treatment of calcified coronary lesions. J Interv Cardiol. 2010 Jun;23(3):240-8. doi: 10.1111/j.1540-8183.2010.00547.x.</citation>
    <PMID>20636844</PMID>
  </reference>
  <reference>
    <citation>Hamon M, Niculescu R, Deleanu D, Dorobantu M, Weissman NJ, Waksman R. Clinical and angiographic experience with a third-generation drug-eluting Orsiro stent in the treatment of single de novo coronary artery lesions (BIOFLOW-I): a prospective, first-in-man study. EuroIntervention. 2013 Jan 22;8(9):1006-11. doi: 10.4244/EIJV8I9A155.</citation>
    <PMID>23339805</PMID>
  </reference>
  <reference>
    <citation>Prati F, Regar E, Mintz GS, Arbustini E, Di Mario C, Jang IK, Akasaka T, Costa M, Guagliumi G, Grube E, Ozaki Y, Pinto F, Serruys PW; Expert's OCT Review Document. Expert review document on methodology, terminology, and clinical applications of optical coherence tomography: physical principles, methodology of image acquisition, and clinical application for assessment of coronary arteries and atherosclerosis. Eur Heart J. 2010 Feb;31(4):401-15. doi: 10.1093/eurheartj/ehp433. Epub 2009 Nov 4. Review.</citation>
    <PMID>19892716</PMID>
  </reference>
  <reference>
    <citation>Kawamori H, Shite J, Shinke T, Otake H, Matsumoto D, Nakagawa M, Nagoshi R, Kozuki A, Hariki H, Inoue T, Osue T, Taniguchi Y, Nishio R, Hiranuma N, Hirata K. Natural consequence of post-intervention stent malapposition, thrombus, tissue prolapse, and dissection assessed by optical coherence tomography at mid-term follow-up. Eur Heart J Cardiovasc Imaging. 2013 Sep;14(9):865-75. doi: 10.1093/ehjci/jes299. Epub 2013 Jan 4.</citation>
    <PMID>23291393</PMID>
  </reference>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 13, 2015</study_first_submitted>
  <study_first_submitted_qc>July 16, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 20, 2015</study_first_posted>
  <last_update_submitted>March 8, 2018</last_update_submitted>
  <last_update_submitted_qc>March 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atherosclerosis</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

